EU MDR Labeling – Are You Prepared?

Need help with your company’s MDR labeling process?
Definitions to Know
Label
Written, printed or graphic information appearing either on the device itself, or on the packaging of each unit or on the packaging of multiple devices.
Instructions for Use
The information provided by the manufacturer to inform the user of a device’s intended purpose and proper use and of any precautions to be taken, for example: websites, GUDID, EUDAMED, marketing materials.
Labeling
Published information regarding the identification, use, specifications, manufacture or limitations of a medical device.
Did you know? The word information appears 362 times in the regulation, more than any other word including risk.
Prohibited Acts (Article 7)
Ensure you do not mislead the user or the patient about the device’s intended purpose, safety and performance by:
- Attributing functions and properties to the device which the device does not have.
- Failing to inform the user or the patient of a likely risk.
Economic Operators (Articles 13, 16)
- Indicate company name and the address. Do not obscure the label provided by the manufacturer.
- If a distributor or importer modifies a device, be sure to indicate the activity carried out together with its name, trade name or trademark and the address of the distributor or importer.
Labeling / IFU Accompanying the Device (Articles 18, 21)
You need to provide instructions for use (IFU) along with your device. The IFU should include:
- Cleaning and disinfection procedures.
- Packaging and validated method of re-sterilization.
- Information on appropriate processes for reuse.
- Maximum number of reuses.
- Signs of material degradation.
- Procedures for safe disposal of devices after use.
- For devices intended for use by lay persons, note the circumstances in which the user should consult a health care professional.
Content of the Device Labels (Articles 20, 22, 27)
On your label you will need to indicate:
- If the device contains or incorporates a medicinal substance, a human blood or plasma derivative, or tissues or cells.
- Hazardous substance information.
- If the device is sterile, indication of its sterile state and the sterilization method.
How NSF Can Help You

What’s New with NSF

NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation
May 20, 2026NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
Sign up to our Food and Wellness Newsletter
March 31, 2026Stay informed with our bi-monthly newsletter, providing updates on emerging trends, industry developments, and key insights from across the food and nutrition industry. Subscribe today to stay ahead.